- Deal Sheet
- Posts
- Deal Sheet, Issue #3 (Blinded)
Deal Sheet, Issue #3 (Blinded)
Welcome to Issue #3 of Deal Sheet, brought to you by Last Money In
Confidentiality Notice: The contents of the Deal Sheet are strictly confidential and may include proprietary or otherwise sensitive information. Subscribers shall not share the contents with non-subscribers or use them for any purpose other than evaluating the presented investment opportunities per the intended use. If a user shares any information or the deal links provided in the Deal Sheet with a non-subscriber, they will forfeit their membership with no refund. An additional important investor disclaimer is presented at the bottom.
You can upgrade here to gain access to these deals.
This week's deals are below.
Deal #1 → A startup that sells canned mountain water marketed towards health-conscious consumers who want an alternative to sugary drinks.
Deal Highlights:
This company has everything in place to build the next Celsius, Monster Energy, etc.
The Company reportedly tapped Goldman Sachs for a 2024 IPO. This is a unique opportunity to get in before then.
The company reported estimating doing over $250M in 2023 revenue
10% Carry Deal Link = Sign up for Deal Sheet now!
Deal #2 → A platform offering bookkeeping, receivables & payables management as an all-in-one SaaS to SMBs. Positioned at the intersection of neo-banking and SaaS, the company aspires to serve as a comprehensive financial hub for SMBs
Deal Highlights:
Series A round led by Tier 1 VC, Accel
Demonstrated remarkable growth: 1,620% MRR growth in 22 months with ~65% gross margin.
3 key applications of AI set this company apart. Robotic Process Automation (RPA), Machine Learning, and Generative AI.
10% Carry Deal Link = Sign up for Deal Sheet now!
Deal #3 → Precision medicine company transforming the future of targeted cancer treatment.
Deal Highlights:
Growth round led by a16z and Section 32
Leveraging a new CRISPR-enabled platform to profile and understand cancer in unprecedented and patient-specific detail.
10% Carry Deal Link = Sign up for Deal Sheet now!
You can upgrade here to gain full access to these deals.
Important Disclaimer: The information provided about startup investment opportunities is intended for general information and initial analysis purposes only. It does not constitute professional financial, investment, or legal advice. While efforts are made to ensure accuracy, no guarantees or warranties of any kind are provided.
Investing in startups involves substantial risk, including the risk of losing your entire investment. Neither Last Money In nor any of its owners, partners, employees or associates, nor the Deal Sheet platform or its operators, are recommending or making any guarantees regarding any particular investment. All investment decisions are made independently and at your own risk.
By voluntarily choosing to access deal information and use the Deal Sheet platform, you demonstrate understanding and acceptance that startup investments generally result in total loss. To the maximum extent permitted by law, you waive and release any claims of liability against Deal Sheet, Last Money In, and any of their respective owners, operators, partners, employees, or associates related to losses, damages (direct or indirect), incomplete or inaccurate information, or any other grievances related to investments you chose to make.
✍️ Curated by Zachary (Calm Ventures) and Alex (Riverside Ventures)
Back our Syndicates: